Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial

Chao Gao^{1

2

3}, Norihiro Kogame⁴, Faisal Sharif³, Pieter C Smits⁵, Pim Tonino⁶, Sjoerd Hofma⁷, Raul Moreno⁸, Anirban Choudhury⁹, Ivo Petrov¹⁰, Angel Cequier¹¹, Antonio Colombo¹², Upendra Kaul¹³, Azfar Zaman¹⁴, Robbert J de Winter⁴, Yoshinobu Onuma³, Patrick W Serruys^{3

15}

Affiliations

¹ Department of Cardiology, Xijing hospital, Xi'an, China (C.G.).
² Department of Cardiology, Radboud University, Nijmegen, the Netherlands (C.G.).
³ Department of Cardiology, National University of Ireland Galway (C.G., F.S., Y.O., P.W.S.).
⁴ Amsterdam UMC, University of Amsterdam, the Netherlands (N.K., R.J.d.W.).
⁵ Maasstad Ziekenhuis, Rotterdam, the Netherlands (P.C.S.).
⁶ Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands (P.T.).
⁷ Medical Centre Leeuwarden, the Netherlands (S.H.).
⁸ Cardiology Department, La Paz University Hospital, Madrid, Spain (R.M.).
⁹ Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (A. Choudhury).
¹⁰ Acibadem City Clinic Cardiovascular Center, Sofia, Bulgaria (I.P.).
¹¹ University Hospital of Bellvitge, Barcelona, Spain (A. Cequier).
¹² Division of Interventional Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (A. Colombo).
¹³ Academics and Research, Batra Hospital and Medical Research Center, New Delhi, India (U.K.).
¹⁴ Freeman Hospital, Newcastle University, and Newcastle upon Tyne Hospitals NHS Trust, Newcastle, United Kingdom (A.Z.).
¹⁵ NHLI, Imperial College London, United Kingdom (P.W.S.).

Multicenter Study

Chao Gao et al. Circ Cardiovasc Interv. 2021 Mar.

. 2021 Mar;14(3):e010312.

doi: 10.1161/CIRCINTERVENTIONS.120.010312. Epub 2021 Mar 9.

¹ Department of Cardiology, Xijing hospital, Xi'an, China (C.G.).
² Department of Cardiology, Radboud University, Nijmegen, the Netherlands (C.G.).
³ Department of Cardiology, National University of Ireland Galway (C.G., F.S., Y.O., P.W.S.).
⁴ Amsterdam UMC, University of Amsterdam, the Netherlands (N.K., R.J.d.W.).
⁵ Maasstad Ziekenhuis, Rotterdam, the Netherlands (P.C.S.).
⁶ Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands (P.T.).
⁷ Medical Centre Leeuwarden, the Netherlands (S.H.).
⁸ Cardiology Department, La Paz University Hospital, Madrid, Spain (R.M.).
⁹ Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (A. Choudhury).
¹⁰ Acibadem City Clinic Cardiovascular Center, Sofia, Bulgaria (I.P.).
¹¹ University Hospital of Bellvitge, Barcelona, Spain (A. Cequier).
¹² Division of Interventional Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (A. Colombo).
¹³ Academics and Research, Batra Hospital and Medical Research Center, New Delhi, India (U.K.).
¹⁴ Freeman Hospital, Newcastle University, and Newcastle upon Tyne Hospitals NHS Trust, Newcastle, United Kingdom (A.Z.).
¹⁵ NHLI, Imperial College London, United Kingdom (P.W.S.).

No abstract available

Keywords: death; drug-eluting stent; sirolimus; stents.

Publication types